130 related articles for article (PubMed ID: 11848553)
1. Stage IV ovarian cancer: prognostic factors and survival beyond 5 years.
Scholz HS; Benedicic C; Haas J; Tamussino K; Petru E
Anticancer Res; 2001; 21(5):3729-32. PubMed ID: 11848553
[TBL] [Abstract][Full Text] [Related]
2. Aggressive surgical strategies in advanced ovarian cancer: a monocentric study of 203 stage IIIC and IV patients.
Colombo PE; Mourregot A; Fabbro M; Gutowski M; Saint-Aubert B; Quenet F; Gourgou S; Rouanet P
Eur J Surg Oncol; 2009 Feb; 35(2):135-43. PubMed ID: 18289825
[TBL] [Abstract][Full Text] [Related]
3. The recurrence and the overall survival rates of ovarian serous borderline neoplasms with noninvasive implants is time dependent.
Silva EG; Gershenson DM; Malpica A; Deavers M
Am J Surg Pathol; 2006 Nov; 30(11):1367-71. PubMed ID: 17063075
[TBL] [Abstract][Full Text] [Related]
4. [Analysis of risk factors for epithelial ovarian cancer recurrence].
Liu S; Liu JH; Huang H; Peng XP; Wang YM
Ai Zheng; 2003 Nov; 22(11):1197-200. PubMed ID: 14613652
[TBL] [Abstract][Full Text] [Related]
5. Primary ovarian cancer at National Taiwan University Hospital: 1980-1989.
Chen CK; Chow SN; Chen RJ; Chen YP; Huang LC; Wang LI; Lin YH; Huang SC
Int Surg; 1994; 79(1):48-51. PubMed ID: 8063555
[TBL] [Abstract][Full Text] [Related]
6. Effect of adjuvant paclitaxel and carboplatin for advanced stage epithelial ovarian cancer: a population-based cohort study of all patients in western Sweden with long-term follow-up.
Akeson M; Zetterqvist BM; Dahllöf K; Brännström M; Horvath G
Acta Obstet Gynecol Scand; 2008; 87(12):1343-52. PubMed ID: 18951208
[TBL] [Abstract][Full Text] [Related]
7. Serum CA-125 level after 6 cycles of primary adjuvant chemotherapy is a useful prognostic factor for complete responders' survival in patients with advanced epithelial ovarian cancer.
Kim HS; Park NH; Chung HH; Kim JW; Song YS; Kang SB
Onkologie; 2008 Jun; 31(6):315-20. PubMed ID: 18547972
[TBL] [Abstract][Full Text] [Related]
8. Tumor residual after surgical cytoreduction in prediction of clinical outcome in stage IV epithelial ovarian cancer: a Gynecologic Oncology Group Study.
Winter WE; Maxwell GL; Tian C; Sundborg MJ; Rose GS; Rose PG; Rubin SC; Muggia F; McGuire WP;
J Clin Oncol; 2008 Jan; 26(1):83-9. PubMed ID: 18025437
[TBL] [Abstract][Full Text] [Related]
9. Prognostic factors for complete debulking in advanced ovarian cancer and its impact on survival. An exploratory analysis of a prospectively randomized phase III study of the Arbeitsgemeinschaft Gynaekologische Onkologie Ovarian Cancer Study Group (AGO-OVAR).
Wimberger P; Lehmann N; Kimmig R; Burges A; Meier W; Du Bois A;
Gynecol Oncol; 2007 Jul; 106(1):69-74. PubMed ID: 17397910
[TBL] [Abstract][Full Text] [Related]
10. Effect of progesterone combined with chemotherapy on epithelial ovarian cancer.
Chen X; Feng Y
Chin Med J (Engl); 2003 Mar; 116(3):388-91. PubMed ID: 12781043
[TBL] [Abstract][Full Text] [Related]
11. Influence of the gynecologic oncologist on the survival of ovarian cancer patients.
Chan JK; Kapp DS; Shin JY; Husain A; Teng NN; Berek JS; Osann K; Leiserowitz GS; Cress RD; O'Malley C
Obstet Gynecol; 2007 Jun; 109(6):1342-50. PubMed ID: 17540806
[TBL] [Abstract][Full Text] [Related]
12. Specialized care and survival of ovarian cancer patients in The Netherlands: nationwide cohort study.
Vernooij F; Heintz AP; Witteveen PO; van der Heiden-van der Loo M; Coebergh JW; van der Graaf Y
J Natl Cancer Inst; 2008 Mar; 100(6):399-406. PubMed ID: 18334710
[TBL] [Abstract][Full Text] [Related]
13. Prognostic factors for high-risk early-stage epithelial ovarian cancer: a Gynecologic Oncology Group study.
Chan JK; Tian C; Monk BJ; Herzog T; Kapp DS; Bell J; Young RC;
Cancer; 2008 May; 112(10):2202-10. PubMed ID: 18348296
[TBL] [Abstract][Full Text] [Related]
14. The results of treatment of epithelial ovarian cancer after centralisation of primary surgery. Results from North Jutland, Denmark.
Soegaard Andersen E; Knudsen A; Svarrer T; Lund B; Nielsen K; Grove A; Tetsche M
Gynecol Oncol; 2005 Dec; 99(3):552-6. PubMed ID: 16150480
[TBL] [Abstract][Full Text] [Related]
15. Radical surgery-peritonectomy and intraoperative intraperitoneal chemotherapy for the treatment of peritoneal carcinomatosis in recurrent or primary ovarian cancer.
Rufián S; Muñoz-Casares FC; Briceño J; Díaz CJ; Rubio MJ; Ortega R; Ciria R; Morillo M; Aranda E; Muntané J; Pera C
J Surg Oncol; 2006 Sep; 94(4):316-24. PubMed ID: 16917864
[TBL] [Abstract][Full Text] [Related]
16. [Impact of dose delivery of postoperative first-line chemotherapy on prognosis of stage III C epithelial ovarian carcinoma].
Zhao XD; Zhang Q; Zhang Y
Ai Zheng; 2005 Aug; 24(8):1002-5. PubMed ID: 16086882
[TBL] [Abstract][Full Text] [Related]
17. Relapse and survival in early-stage ovarian cancer.
Lenhard SM; Bufe A; Kümper C; Stieber P; Mayr D; Hertlein L; Kirschenhofer A; Friese K; Burges A
Arch Gynecol Obstet; 2009 Jul; 280(1):71-7. PubMed ID: 19093129
[TBL] [Abstract][Full Text] [Related]
18. Surgery by consultant gynecologic oncologists improves survival in patients with ovarian carcinoma.
Engelen MJ; Kos HE; Willemse PH; Aalders JG; de Vries EG; Schaapveld M; Otter R; van der Zee AG
Cancer; 2006 Feb; 106(3):589-98. PubMed ID: 16369985
[TBL] [Abstract][Full Text] [Related]
19. The clinical significance of malignant pleural effusions in patients with optimally debulked ovarian carcinoma.
Eitan R; Levine DA; Abu-Rustum N; Sonoda Y; Huh JN; Franklin CC; Stevens TA; Barakat RR; Chi DS
Cancer; 2005 Apr; 103(7):1397-401. PubMed ID: 15726548
[TBL] [Abstract][Full Text] [Related]
20. Advanced epithelial ovarian cancer in the elderly: chemotherapy tolerance and outcome.
Efstathiou E; Dimopoulos MA; Bozas G; Kastritis E; Moulopoulos LA; Rodolakis A; Vlahos G; Gika D; Papadimitriou C; Bamias A
Anticancer Res; 2007; 27(1B):611-7. PubMed ID: 17348450
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
